Home
/

TSH: The Pituitary Signal, Not the Thyroid Hormone

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

TSH is the pituitary signal telling the thyroid how hard to work; most labs report roughly 0.4 to 4–5 mIU/L, though older adults trend higher and pregnancy lowers it. Rising TSH reflects the brain sensing too little thyroid hormone, typically from autoimmune thyroiditis, while falling TSH points toward hyperthyroidism. Pairing it with free T4 and thyroid antibodies identifies the cause.

Read more →
Table of contents

What people mean when they say TSH

TSH, or thyroid-stimulating hormone, is a pituitary signal that tells your thyroid gland how hard to work. Picture a thermostat sending instructions to the heater: when thyroid hormone levels run low, the pituitary turns the dial up; when they run high, it turns the dial down. TSH is synthesized in the anterior pituitary and regulated by TRH from the hypothalamus with feedback from circulating thyroid hormones, primarily free thyroxine (free T4) and triiodothyronine (free T3). A higher TSH generally means the brain senses too little thyroid hormone and is asking for more; a lower TSH means the brain senses enough or too much and is easing off.

The pituitary feedback loop behind your TSH number

Your thyroid runs your metabolic tempo — how quickly cells turn food into energy, how fast your heart beats, how warm your body stays. The brain watches that tempo with exquisite sensitivity and uses TSH to nudge it up or down.

Here's the loop. The hypothalamus releases TRH, which prompts the pituitary to release TSH. TSH tells the thyroid to make T4 and T3. As T4 and T3 rise, they signal back to the brain to dial TSH down — a clean negative feedback loop, like cruise control keeping your speed steady on a hill. Importantly, TSH measures the brain's demand on the thyroid, not the thyroid's actual output. A suppressed TSH from a pituitary problem can coexist with low thyroid hormone, not high.

Life complicates the loop in predictable ways. Overnight, TSH naturally climbs and peaks in the early morning, then drifts lower by afternoon. Acute illness and high stress can suppress TSH — a well-described pattern in critical care called non-thyroidal illness. High-dose biotin supplements can trick certain immunoassays, making TSH look falsely low and free hormones look falsely high. Some people carry rare antibodies or large TSH complexes (macro-TSH) that push measured levels up even when they feel fine.

Training load, calorie intake, and recovery also nudge the axis. Severe calorie deficits and overreaching can lower T3 and subtly shift TSH as the body conserves energy. Iodine intake drives thyroid hormone synthesis; too little or too much can push TSH up as the system tries to stabilize output. Pregnancy temporarily rewires the loop as hCG lightly stimulates the thyroid and normal TSH runs lower, particularly in the first trimester.

The pituitary-thyroid feedback loop also has a known lag: TSH reaches a new steady state approximately 6–8 weeks after a levothyroxine dose change, which matters for interpreting results after any adjustment. Longer-term, persistently suppressed TSH with elevated hormones increases the risk of atrial fibrillation and bone loss, especially in older adults, while markedly elevated TSH with low hormones links to higher LDL cholesterol, slower GI motility, and lower exercise capacity over time. One data point tells you direction; a trend tells you a story.

Low, normal, and high TSH explained

Normal range

Reference intervals describe where most healthy people fall, not a guarantee of perfect health. Many adult labs report roughly 0.4 to 4–5 mIU/L, but ranges vary by assay and population. In older adults, slightly higher TSH values are common and can be normal. In pregnancy, trimester-specific ranges run lower. Same test, different biology, different interpretation.

"Optimal" isn't a universal number; it's the range associated with good outcomes for someone like you. Subclinical patterns — TSH outside range with normal free hormones — sit in between and need context: antibodies, symptoms, lipids, and repeat testing before decisions are made. Results consistent across time, symptoms, and related labs are what turn a "normal" number into useful information.

High TSH

A higher TSH usually means the brain is asking for more thyroid hormone. The most common reason is primary hypothyroidism, where the thyroid is underperforming. That can stem from autoimmune thyroiditis (often flagged by thyroid peroxidase antibodies), iodine deficiency or excess, or recovery after thyroiditis. Lipids may creep up, resting heart rate may slow, and recovery from exercise can feel sluggish.

There are caveats. TSH spikes overnight, so timing matters. After a bout of severe illness, TSH can rebound transiently. Some medications increase TSH signaling or blunt thyroid hormone production, including lithium and amiodarone, while immune checkpoint inhibitors can trigger thyroiditis. Rarely, falsely high TSH occurs from macro-TSH or assay interference — in those cases, people often feel well with normal free T4 and free T3, and specialized lab techniques can sort it out. Confirming with free T4, checking for thyroid antibodies if autoimmune disease is on the table, and looking at trends over several weeks rather than days all sharpen the picture.

Low TSH

A lower TSH suggests the brain is turning down the signal because it senses enough or too much thyroid hormone. Common causes include hyperthyroidism, often from Graves' disease, or transient thyroiditis where stored hormone spills into the blood. People may notice a racing heart, heat intolerance, anxiety, sleep disruption, or unexplained weight loss.

There's nuance here too. In critical illness, TSH can dip modestly without true hyperthyroidism. High-dose biotin can artifactually lower TSH on some assays. Glucocorticoids and dopamine agonists can suppress TSH output. In central hypothyroidism, disease in the pituitary or hypothalamus leads to low or inappropriately normal TSH with low free T4 — not enough signal from the top despite low hormone levels. Pairing TSH with free T4 and, if needed, free T3, and considering clinical context, medications, and supplement exposures, clarifies whether the signal persists or resolves.

Factors that skew TSH between morning draws

Nutrients and micronutrients

Your thyroid needs raw materials. Iodine fuels hormone synthesis, while selenium supports deiodinase enzymes that convert T4 to the more active T3 and protect the gland from oxidative stress. Iron enables thyroid peroxidase, the enzyme that stitches iodine onto tyrosine to build T4 and T3. Zinc participates in thyroid hormone metabolism. Inadequacy in any of these can nudge TSH upward as the brain pushes the thyroid to work harder. Both iodine deficiency and excess can raise TSH as the system tries to stabilize output.

Diurnal rhythm and sleep

TSH follows a circadian rhythm, peaking overnight and dipping through the day. Acute sleep loss can distort that curve, nudging TSH up temporarily. Chronic stress and illness can suppress the signal as the body prioritizes survival. Cortisol and inflammatory cytokines cross-talk with the thyroid axis, subtly changing set points. Consistent morning draw timing improves comparability across tests.

Medications

Several medications shift TSH independently of true thyroid dysfunction. Lithium and amiodarone can alter thyroid hormone production and raise TSH. Glucocorticoids and dopamine agonists suppress TSH output. Immune checkpoint inhibitors can trigger thyroiditis. Metformin may lower TSH in some people with hypothyroidism without changing free T4, according to observational data.

Biotin interference

High-dose biotin, often taken for hair and nails, can distort several thyroid tests on common immunoassay platforms, making TSH read low and free hormones read high. Pausing biotin per lab guidance before a draw removes this confounder.

Illness, pregnancy, and pituitary disease

Non-thyroidal illness (critical illness or severe acute stress) can suppress TSH transiently without true hyperthyroidism. Pregnancy changes the axis, especially in the first trimester as hCG lightly stimulates the thyroid, and postpartum thyroiditis can cause a hyper-then-hypo sequence before settling. Pituitary or hypothalamic disease reframes interpretation entirely, because TSH may not rise even when thyroid hormone is low. Aging shifts the goalposts, with many experts accepting a slightly higher TSH in older adults when free T4 is normal and symptoms are absent.

The thyroid panel that reads TSH in context

TSH is most informative when read alongside the markers that reveal what the thyroid is actually producing and why it may be drifting.

  • Total T4 shows the thyroid's output directly. High TSH with low T4 confirms primary hypothyroidism, while high TSH with normal T4 identifies subclinical hypothyroidism.
  • Free T3 is the active hormone at the tissue level. When TSH is low-normal and symptoms persist, low free T3 from impaired conversion is the explanation TSH alone cannot provide.
  • TPO antibodies explain why TSH is drifting upward by identifying autoimmune thyroiditis as the underlying cause.
  • Thyroglobulin antibody (TgAb) completes the autoimmune picture; relevant when TPO is negative but Hashimoto's is suspected, or in thyroid cancer surveillance where TgAb interferes with the Tg tumor marker.
  • T3 Uptake helps correct for TBG-binding shifts when total T4 and TSH are discordant, particularly during pregnancy or estrogen therapy when TBG rises independently of thyroid function.

When to retest TSH after a dose change

The pituitary-thyroid feedback loop has a known lag: TSH reaches a new steady state approximately 6–8 weeks after a levothyroxine dose change. Retesting before that window closes will not reflect the new equilibrium and can lead to unnecessary further adjustments. The practical guidance follows from that biology.

  • After any dose adjustment: retest at 6–8 weeks. Do not retest within 4 weeks of a change.
  • Stable, no known thyroid condition: annual testing is appropriate for most adults.
  • Draw timing: TSH follows a mild diurnal rhythm and is highest in the early morning. Consistent morning draws improve comparability across tests.
  • Biotin: pause high-dose biotin per lab guidance before the draw to avoid immunoassay interference.
  • Same lab, same assay method across serial tests reduces inter-assay variability.

When TSH results warrant an endocrine conversation

TSH is small, cheap, and information-dense. Trended alongside free T4 and symptoms, it provides early warning on shifts in metabolism, recovery, and cardiovascular risk. Adding antibodies when appropriate moves interpretation from "what is happening" to "why is it happening."

A result outside the reference range on a single draw is a prompt for context, not necessarily action. Persistent elevation or suppression across two or more draws, results that diverge from how you feel, or TSH moving in the wrong direction after a dose change are all reasons to bring the full panel — TSH, free T4, free T3, and relevant antibodies — to a clinician for evaluation.

Superpower's comprehensive biomarker panel places TSH alongside free T4, free T3, targeted antibodies, lipids, glucose metrics, iron status, and inflammation markers to map how energy, immunity, and recovery work together. That big-picture view supports informed, personalized decisions in partnership with a qualified clinician — moving beyond population averages toward what's right for you. Learn more about the Superpower approach or visit superpower.com to get started.

FAQs

TSH, or thyroid-stimulating hormone, is a pituitary hormone that signals the thyroid gland to produce T3 and T4, the hormones that regulate metabolism, body temperature, heart rate, and mood. Because TSH rises when thyroid output falls short and decreases when it is excessive, TSH acts as a sensitive early indicator of thyroid function — making it the standard first-line test for thyroid assessment.
TSH is measured from a standard blood draw and reported in milli-international units per liter (mIU/L). No fasting is required, though consistency in testing time matters: TSH follows a mild daily rhythm, with levels slightly higher in the early morning. A single TSH result is often sufficient as an initial screen, but trends across multiple tests provide more useful clinical context.
The conventional reference range for TSH is approximately 0.4 to 4.0 mIU/L, though some clinicians prefer a tighter range of 0.5 to 2.5 mIU/L for optimal function. A TSH above 4.0 mIU/L may indicate hypothyroidism (underactive thyroid), while a result below 0.4 mIU/L may indicate hyperthyroidism (overactive thyroid). Reference ranges vary by lab and individual context, so results should always be reviewed by a clinician.
An elevated TSH most commonly reflects primary hypothyroidism, where the thyroid gland is not producing enough hormone and the pituitary compensates by releasing more TSH. Common causes include Hashimoto's thyroiditis (an autoimmune condition), iodine deficiency, thyroid surgery, and certain medications. Subclinical hypothyroidism — mildly elevated TSH with normal free T4 — is among the most common thyroid patterns found on routine testing.
High TSH (indicating an underactive thyroid) is associated with fatigue, weight gain, cold intolerance, constipation, dry skin, brain fog, and low mood. Low TSH (indicating an overactive thyroid) is linked to unexplained weight loss, rapid heartbeat, heat intolerance, anxiety, and disrupted sleep. Many of these symptoms overlap with other conditions, which is why TSH testing is important for accurate differentiation.
Chronic stress and sleep deprivation can modestly affect TSH by altering pituitary signaling. Severe caloric restriction may also shift TSH as the body down-regulates metabolism. Iodine intake influences thyroid hormone synthesis, though both very low and excessive iodine can be disruptive. For most people with a thyroid condition, lifestyle factors have a supporting role, not a primary one, in TSH management.

References

  1. Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., Sawka, A. M., & American Thyroid Association Task Force on Thyroid Hormone Replacement (2014). Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid, 24(12), 1670-751. https://doi.org/10.1089/thy.2014.0028
  2. Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., Peeters, R. P., & Sullivan, S. (2017). 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid, 27(3), 315-389. https://doi.org/10.1089/thy.2016.0457
  3. Singh, H., Shahid, M. Z., Harrison, S. L., Lane, D. A., Lip, G. Y. H., & Logantha, S. J. R. J. (2024). Subclinical thyroid dysfunction and the risk of incident atrial fibrillation: A systematic review and meta-analysis. PloS one, 19(1), e0296413. https://doi.org/10.1371/journal.pone.0296413
  4. Kotwal, A., Cortes, T., Genere, N., Hamidi, O., Jasim, S., Newman, C. B., Prokop, L. J., Murad, M. H., & Alahdab, F. (2020). Treatment of Thyroid Dysfunction and Serum Lipids: A Systematic Review and Meta-analysis. The Journal of clinical endocrinology and metabolism, 105(12). https://doi.org/10.1210/clinem/dgaa672
  5. Favresse, J., Burlacu, M. C., Maiter, D., & Gruson, D. (2018). Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm. Endocrine reviews, 39(5), 830-850. https://doi.org/10.1210/er.2018-00119

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey